Affiliations: [a] Department of Biophysics, All India Institute of Medical Sciences, New Delhi, India
| [b] Department of Geriatric Medicine, All India Institute of Medical Sciences, New Delhi, India
| [c] Department of Neurology, All India Institute of Medical Sciences, New Delhi, India
| [d] Department of Biostatistics, All India Institute of Medical Sciences, New Delhi, India
Correspondence:
[*]
Correspondence to: Dr. Sharmistha Dey, Department of Biophysics, All India Institute of Medical Sciences,
Ansari Nagar, New Delhi - 110029, India. Tel.: +91 11 26546435; Fax: +91 11 26588641;
E-mail: [email protected].
Abstract: Sestrins (sesn) are highly conserved proteins that play an important neuroprotective role, in part as a consequence of their antioxidative capacity, which prevents reactive oxygen species formation. In this study, we evaluated the concentrations of sesn1 and sesn2 in the serum of 41 Alzheimer’s disease (AD) patients, 27 mild cognitive impairment (MCI), and 60 elderly controls, by surface plasmon resonance, which was validated by using western blot. Moreover, the mRNA level of sestrins in all the study groups was determined by real time polymerase chain reaction. The results showed significant overexpression of serum sesn2 protein and mRNA levels in the AD group compared to MCI and elderly control groups. A difference in serum sesn2 concentration between MCI and the control group was also evident. ROC analysis showed highly sensitive, selective cutoff values for sens2 in the differentiation of AD, MCI, and controls. No significant difference in sesn1 level was observed among the study groups. This study highlights the important role of sesn2 in the progression of the AD, indicating its potential utility as a protein marker in this devastating disease.
